IP Verse

Dipharma patent opposition analysis

Get complete Patent Opposition Report for Dipharma

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Dipharma

Explore patent oppositions filed by Dipharma against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3461503	Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring	BIOMARIN PHARMACEUTICAL	Nov 9, 2022
EP3138566	Treatment Of Phenylketonuria With Bh4	BIOMARIN PHARMACEUTICAL	Oct 26, 2022
EP2545939	Methods Of Administering Tetrahydrobiopterin, Associated Compositions, And Methods Of Measuring	BIOMARIN PHARMACEUTICAL	Jul 13, 2021
EP2981520	New Process For The Synthesis Of 1-(2-((2,4-Dimethylphenyl)Thio)Phenyl)Piperazine	LEK PHARMACEUTICALS DD	Dec 5, 2019

Latest patents of Dipharma opposed by its competitors

Explore Dipharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent Number	Grant Date	Title	Total Oppositions
EP3564224	Sep 29, 2021	Crystalline Form Of Vortioxetine Hydrobromide As Antidepressant Drug	1

Top competitors of Dipharma

ACINO PHARMA

DEVELCO PHARMA SCHWEIZ

ETHYPHARM